Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 LinkEye LET Apr 25, 2025 0.00 +0.02   
 LiquidApps DAPP Apr 25, 2025 0.00 +0.94   
 Lisk LSK Apr 25, 2025 0.54 +2.46   
 Litecoin LTC Apr 25, 2025 83.75 +2.29   
 LitecoinCash LCC Apr 25, 2025 0.01 +0.93   
 Litentry LIT Apr 25, 2025 0.48 -0.86   
 LIVEEN VEEN Sep 26, 2023 0.00 +0.72   
 LockTrip LOCK Nov 29, 2021 0.02 -2.20   
 Loki LOKI Sep 26, 2023 0.68 +0.87   
 Loom Network LOOM Apr 25, 2025 0.02 +4.63   
 Loopring LRC Apr 25, 2025 0.10 +3.26   
 LTO Network LTO Apr 25, 2025 0.04 +9.41   
 LUKSO LYXE Apr 25, 2025 4.15 +0.01   
 Lunes LUNES Apr 25, 2025 0.00 +0.01   
 Lunyr LUN Apr 25, 2025 0.02 +0.61   
 Lympo LYM Apr 25, 2025 0.00 +0.62   
 Machine Xchange Coin MXC Apr 25, 2025 0.00 +2.16   
 MaidSafe Coin MAID Apr 25, 2025 0.08 -42.79   
 MainCoin MNC Apr 25, 2025 0.01 +0.61   
 Maker MKR Apr 25, 2025 1 496.62 +1.60   
 MANTRA OM Apr 25, 2025 0.51 -2.49   
 MarcoPolo Protocol MAP Apr 25, 2025 0.01 +0.01   
 Marshal Lion Group Coin MLGC Sep 26, 2023 1.32 +0.72   
 Matrix AI Network MXAI Sep 26, 2023 0.01 +0.72   
 Matryx MTX Apr 25, 2025 0.00 +0.01   
 Measurable Data Token MSDT Sep 26, 2023 0.09 -0.01   
 MediBloc MEDIB Aug 29, 2021 0.07 +0.78   
 Medicalchain MDCL Apr 25, 2025 0.00 -10.29   
 MediShares MDS Apr 25, 2025 0.00 +119.82   
 MediterraneanCoin MED Apr 25, 2025 0.01 +0.76   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Data:


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.